This document discusses translating large datasets into therapies and medical insights. It describes how over 1 trillion points of biological and clinical data are being analyzed across thousands of genes, compounds, and cell types. The goal is to identify new drug targets and repurpose existing drugs for additional diseases. As an example, a drug used for seizures was found to help a rat model of inflammatory bowel disease. Open data from clinical trials is also being reanalyzed to find new predictors of patient responses and outcomes. The work involves collaborations across multiple research institutions and industries.